نتائج البحث

Anterior mediastinal tracheostomy - a salvage procedure for tracheal necrosis after thyroidectomy for medullary thyroid cancer: a case-report.

• Authors : Hemead H; Department of Thoracic Surgery, University Hospitals Birmingham, Birmingham, UK.; Department of Cardiothoracic Surgery, Alexandria University, Alexandria, Egypt.

Subjects: Thyroid Neoplasms*/Thyroid Neoplasms*/Thyroid Neoplasms*/surgery ; Thyroid Neoplasms*/Thyroid Neoplasms*/Thyroid Neoplasms*/pathology ; Thyroidectomy*/Thyroidectomy*/Thyroidectomy*/adverse effects Thyroid cancer, medullary

• Source: World journal of surgical oncology [World J Surg Oncol] 2025 Jan 16; Vol. 23 (1), pp. 14. Date of Electronic Publication: 2025 Jan 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer.

• Authors : Alqahtani T; Department of Pharmaceutical Sciences, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. .; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. .

Subjects: Proto-Oncogene Proteins c-ret*/Proto-Oncogene Proteins c-ret*/Proto-Oncogene Proteins c-ret*/genetics ; Proto-Oncogene Proteins c-ret*/Proto-Oncogene Proteins c-ret*/Proto-Oncogene Proteins c-ret*/metabolism ; Proto-Oncogene Proteins c-ret*/Proto-Oncogene Proteins c-ret*/Proto-Oncogene Proteins c-ret*/antagonists & inhibitors Thyroid cancer, medullary

• Source: BMC cancer [BMC Cancer] 2024 Dec 23; Vol. 24 (1), pp. 1569. Date of Electronic Publication: 2024 Dec 23.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid RET Pathogenic Variants in Medullary Thyroid Cancer/Multiple Endocrine Neoplasia Type 2 (MEN2).

• Authors : Stanescu LS; PhD Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 0505474 Bucharest, Romania.; Department of Clinical Endocrinology V, C.I. Parhon National Institute of Endocrinology, 011863 Bucharest, Romania.

Subjects: Proto-Oncogene Proteins c-ret*/Proto-Oncogene Proteins c-ret*/Proto-Oncogene Proteins c-ret*/genetics ; Thyroid Neoplasms*/Thyroid Neoplasms*/Thyroid Neoplasms*/genetics ; Thyroid Neoplasms*/Thyroid Neoplasms*/Thyroid Neoplasms*/pathology Thyroid cancer, medullary

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 10; Vol. 25 (18). Date of Electronic Publication: 2024 Sep 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

• Authors : National Cancer Institute (NCI)

• Source: Utilization of the Natural History of Medullary Thyroid Carcinoma to Inform Advanced Disease Management

تفاصيل العنوان

Natural History Study of Children and Adults With Medullary Thyroid Cancer

• Source: Longitudinal Assessment and Natural History Study of Children and Adults With MEN2A or MEN2B With or Without Medullary Thyroid Carcinoma

تفاصيل العنوان

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)

• Authors : Eli Lilly and Company

• Source: A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve,

تفاصيل العنوان

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation (LIBRETTO-321)

• Source: A Phase 2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including Rearranged in Transfection (RET) Fusion-Positive Solid Tumors,

تفاصيل العنوان

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) (LIBRETTO-001)

• Authors : Loxo Oncology, Inc.

• Source: A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary

تفاصيل العنوان

Predictive Factors for Medullary Thyroid Cancer Aggressiveness (MYELO)

• Authors : Papavramidis Theodossis, Associate Professor

• Source: Predective Factors for Tumor Aggressiveness in Medullary Thyroid Cancer

تفاصيل العنوان

CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer.

• Authors : Hińcza-Nowak K; Department of Molecular Diagnostics, Holycross Cancer Centre, 25-734 Kielce, Poland.; Endocrinology Clinic, Holycross Cancer Centre, 25-734 Kielce, Poland.

Subjects: Carcinoma, Medullary*/Carcinoma, Medullary*/Carcinoma, Medullary*/metabolism ; Thyroid Neoplasms*/Thyroid Neoplasms*/Thyroid Neoplasms*/pathology ; Carcinoma, Neuroendocrine*/Carcinoma, Neuroendocrine*/Carcinoma, Neuroendocrine*/therapyThyroid cancer, medullary

• Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 12; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان